Incyte
INCY
#1179
Rank
S$24.55 B
Marketcap
S$123.37
Share price
1.73%
Change (1 day)
48.23%
Change (1 year)

Earnings for Incyte (INCY)

Earnings in 2025 (TTM): S$2.14 Billion

According to Incyte's latest financial reports the company's current earnings are S$5.14 Billion. , an increase over its 2024 earnings that were of S$0.40 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Incyte from 1994 to 2025

Annual earnings

Year Earnings Change
2025 S$2.14 B425.68%
2024 S$0.40 B-62.04%
2023 S$1.07 B57.66%
2022 S$0.68 B-7.24%
2021 S$0.73 B-345.65%
2020 -S$0.3 Billion-147.7%
2019 S$0.62 B322.02%
2018 S$0.14 B-136.94%
2017 -S$0.41 Billion-390.76%
2016 S$0.13 B1322%
2015 S$9.71 M-115.56%
2014 -S$62.44 Million-41.4%
2013 -S$0.11 Billion87.67%
2012 -S$56.78 Million-74.9%
2011 -S$0.23 Billion843.59%
2010 -S$23.97 Million-88.68%
2009 -S$0.22 Billion1.37%
2008 -S$0.21 Billion86.16%
2007 -S$0.12 Billion17.64%
2006 -S$95.38 Million-28.62%
2005 -S$0.14 Billion-36.1%
2004 -S$0.21 Billion-2.03%
2003 -S$0.22 Billion22.26%
2002 -S$0.18 Billion-27.39%
2001 -S$0.25 Billion198.72%
2000 -S$80.5 Million132.2%
1999 -S$34.67 Million-556.86%
1998 S$7.58 M-37.23%
1997 S$12.08 M-259.32%
1996 -S$7.59 Million-45.87%
1995 -S$14.02 Million-9.17%
1994 -S$15.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
S$21.02 B 882.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$13.10 B 512.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$33.09 B 1,445.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$11.54 B 439.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$0.21 B-90.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-S$59.06 Million-102.76%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-S$89.05 Million-104.16%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-S$37.35 Million-101.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-S$71.44 Million-103.34%๐Ÿ‡บ๐Ÿ‡ธ USA